In this context, the protein S100b is a promising circulating biomarker for the diagnosis of BD, as its detection in acute brain injuries, in neurocritical patients in emergency rooms and ICUs, has been employed in clinical practice for monitoring these patients in many countries. Here, S100B is linked to brain injury.